Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. We are creating next generation immunotherapies using breakthrough de novo protein design technology. We use natural protein complexes as inspiration to develop custom designed proteins with superior pharmaceutical properties.
Location: United States, Washington, Seattle
Employees: 51-200
Founded date: 2019
Investors 2
| Date | Name | Website |
| - | WRF Capita... | wrfseattle... |
| - | Sahsen Ven... | sahsen.com |
Mentions in press and media 3
| Date | Title | Description | Source |
| 12.12.2021 | Neoleukin Therapeutics Announces Preclinical Data Highlighti... | – Poster presentation highlights NL-201 activity in multiple myeloma stem cell transplant model – – ... | marketscre... |
| 19.11.2020 | How One Company Pivoted From Cancer To Coronavirus And Desig... | When the pandemic arrived in the United States, millions of us were sidelined by stay-at-home orders... | forbes.com... |
| 06.08.2019 | Cancer-fighting startup Neoleukin merging with Aquinox in $4... | Neoleukin Therapeutics launched in January with the goal of commercializing a cancer-fighting protei... | geekwire.c... |